Brief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
06/04/2023 21:31
April 6 (Reuters) - Clovis Oncology Inc CLVSQ.PK :
* CLOVIS ONCOLOGY INC - ON APRIL 5, 2023, ENTERED INTO AN
ASSET
PURCHASE AGREEMENT WITH PHARMA& TO SELL PRODUCT BUSINESS FOR
UPFRONT PAYMENT OF $70 MILLION
Further company coverage: CLVSQ.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber